ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Argonaut Therapeutics Limited

Argonaut Therapeutics Limited is an active company incorporated on 8 February 2016 with the registered office located in Oxford, Oxfordshire. Argonaut Therapeutics Limited was registered 9 years ago.
Status
Active
Active since incorporation
Company No
09993166
Private limited company
Age
9 years
Incorporated 8 February 2016
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Submitted
Dated 7 February 2025 (8 months ago)
Next confirmation dated 7 February 2026
Due by 21 February 2026 (3 months remaining)
Last change occurred 1 year 7 months ago
Accounts
Submitted
For period 1 Jul31 Dec 2024 (1 year 6 months)
Accounts type is Total Exemption Full
Next accounts for period 31 December 2025
Due by 30 September 2026 (11 months remaining)
Address
Magdalen Centre Robert Robinson Avenue
Oxford Science Park
Oxford
OX4 4GA
United Kingdom
Address changed on 24 May 2024 (1 year 5 months ago)
Previous address was
Telephone
01865 784000
Email
Unreported
People
Officers
2
Shareholders
1
Controllers (PSC)
1
Director • Cfo • British • Lives in UK • Born in Oct 1966
Director • British • Lives in UK • Born in Nov 1957
Ingenox Therapeutics Limited
PSC
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Celleron Therapeutics Limited
Prof Nicholas Barrie La Thangue and William John Robert Fleming are mutual people.
Active
Ingenox Therapeutics Limited
Prof Nicholas Barrie La Thangue and William John Robert Fleming are mutual people.
Active
Canivax Limited
Prof Nicholas Barrie La Thangue is a mutual person.
Active
Oxford Cancer Biomarkers Limited
Prof Nicholas Barrie La Thangue is a mutual person.
Active
Global Cancer Consultants Limited
Prof Nicholas Barrie La Thangue is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2017–2024)
Period Ended
31 Dec 2024
For period 1 Jul31 Dec 2024
Traded for 18 months
Cash in Bank
£98.54K
Increased by £33.69K (+52%)
Turnover
Unreported
Same as previous period
Employees
5
Decreased by 4 (-44%)
Total Assets
£175.78K
Decreased by £145.2K (-45%)
Total Liabilities
-£13.88K
Decreased by £359.71K (-96%)
Net Assets
£161.9K
Increased by £214.51K (-408%)
Debt Ratio (%)
8%
Decreased by 108.5% (-93%)
Latest Activity
Full Accounts Submitted
1 Month Ago on 23 Sep 2025
Confirmation Submitted
8 Months Ago on 24 Feb 2025
William John Robert Fleming Resigned
1 Year 1 Month Ago on 18 Sep 2024
Accounting Period Extended
1 Year 4 Months Ago on 3 Jul 2024
Inspection Address Changed
1 Year 5 Months Ago on 24 May 2024
Registers Moved To Inspection Address
1 Year 5 Months Ago on 24 May 2024
Confirmation Submitted
1 Year 7 Months Ago on 18 Mar 2024
Full Accounts Submitted
2 Years 1 Month Ago on 26 Sep 2023
Nicholas George Dixon-Clegg Resigned
2 Years 8 Months Ago on 22 Feb 2023
Prof Nicholas Barrie La Thangue Details Changed
9 Years Ago on 8 Feb 2016
Get Credit Report
Discover Argonaut Therapeutics Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Total exemption full accounts made up to 31 December 2024
Submitted on 23 Sep 2025
Director's details changed for Prof Nicholas Barrie La Thangue on 8 February 2016
Submitted on 6 Mar 2025
Confirmation statement made on 7 February 2025 with no updates
Submitted on 24 Feb 2025
Statement by Directors
Submitted on 31 Dec 2024
Resolutions
Submitted on 31 Dec 2024
Statement of capital on 31 December 2024
Submitted on 31 Dec 2024
Solvency Statement dated 31/12/24
Submitted on 31 Dec 2024
Termination of appointment of William John Robert Fleming as a director on 18 September 2024
Submitted on 19 Sep 2024
Current accounting period extended from 30 June 2024 to 31 December 2024
Submitted on 3 Jul 2024
Register(s) moved to registered inspection location 3rd Floor 1 Ashley Road Altrincham Cheshire WA14 2DT
Submitted on 24 May 2024
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year